Altered microRNome profiling in statin-induced HepG2 Cells: a pilot study identifying potential new biomarkers involved in lipid-lowering treatment (2015)
- Authors:
- USP affiliated authors: HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF ; HIRATA, MARIO HIROYUKI - FCF
- Unidade: FCF
- DOI: 10.1007/s10557-015-6627-0
- Subjects: COLESTEROL; BIOMARCADORES; LIPÍDEOS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Cardiovascular Drugs and Therapy
- ISSN: 0920-3206
- Volume/Número/Paginação/Ano: v. 29, n. 6, p. 509-518, 2015
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
ZAMBRANO, Tomás et al. Altered microRNome profiling in statin-induced HepG2 Cells: a pilot study identifying potential new biomarkers involved in lipid-lowering treatment. Cardiovascular Drugs and Therapy, v. 29, n. 6, p. 509-518, 2015Tradução . . Disponível em: https://doi.org/10.1007/s10557-015-6627-0. Acesso em: 23 abr. 2024. -
APA
Zambrano, T., Hirata, R. D. C., Hirata, M. H., Cerda, A., & Salazar, L. A. (2015). Altered microRNome profiling in statin-induced HepG2 Cells: a pilot study identifying potential new biomarkers involved in lipid-lowering treatment. Cardiovascular Drugs and Therapy, 29( 6), 509-518. doi:10.1007/s10557-015-6627-0 -
NLM
Zambrano T, Hirata RDC, Hirata MH, Cerda A, Salazar LA. Altered microRNome profiling in statin-induced HepG2 Cells: a pilot study identifying potential new biomarkers involved in lipid-lowering treatment [Internet]. Cardiovascular Drugs and Therapy. 2015 ; 29( 6): 509-518.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1007/s10557-015-6627-0 -
Vancouver
Zambrano T, Hirata RDC, Hirata MH, Cerda A, Salazar LA. Altered microRNome profiling in statin-induced HepG2 Cells: a pilot study identifying potential new biomarkers involved in lipid-lowering treatment [Internet]. Cardiovascular Drugs and Therapy. 2015 ; 29( 6): 509-518.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1007/s10557-015-6627-0 - Could SNPs predict Cisplatin toxicity?
- Validation of TREML4 mRNA expression and polymorphisms in blood leukocytes as potential biomarker of atherosclerosis
- Bases farmacogenômicas da resistência medicamentosa
- Inclusion body formation in escherichia coli: a procedure for optimizing production of soluble protein in application to human interferon alpha receptor
- Expression of three polypeptide kfragments of human interferon alpha receptor cloning flexibility and optimization of expression efficienty
- Reconhecimento do receptor recombinante de ifn 'ALFA' / 'BETA' humano por anticorpos policlonais de coelho
- Human interferon alpha receptor: identification of the regeion involved in binding to interferon alpha b
- Cloning and expression of treponema pallidium 47 kda antigen in e. Coli dh5 'ALPHA'
- Estratégia de extração de DNA de manchas sanguíneas para testes forensicos por PCR
- Cloning of a fragment of the 5 noncoding region of HCV genome for using as an internal control in PCR
Informações sobre o DOI: 10.1007/s10557-015-6627-0 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
